Literature DB >> 21976780

CJDATS CO-OCCURRING DISORDERS SCREENING INSTRUMENT (CODSI) FOR MENTAL DISORDERS (MD): A Validation Study.

Stanley Sacks1, Gerald Melnick, Carrie Coen, Steve Banks, Peter D Friedmann, Christine Grella, Kevin Knight, Caron Zlotnick.   

Abstract

Three standardized screening instruments-the Global Appraisal of Individual Needs Short Screener (GSS), the Mini-International Neuropsychiatric Interview-Modified (MINI-M), and the Mental Health Screening Form (MHSF)-were compared to two shorter instruments, the 6-item Co-Occurring Disorders Screening Instrument for Mental Disorders (CODSI-MD) and the 3-item CODSI for Severe Mental Disorders (CODSI-SMD) for use with offenders in prison substance-abuse treatment programs. Results showed that the CODSI screening instruments were comparable to the longer instruments in overall accuracy and that all of the instruments performed reasonably well. The CODSI instruments showed sufficient value to justify their use in prison substance-abuse treatment programs and to warrant validation testing in other criminal justice populations and settings.

Entities:  

Year:  2007        PMID: 21976780      PMCID: PMC3184768          DOI: 10.1177/0093854807304430

Source DB:  PubMed          Journal:  Crim Justice Behav        ISSN: 0093-8548


  32 in total

1.  CJDATS Co-Occurring Disorders Screening Instrument for Mental Disorders (CODSI-MD): A Pilot Study.

Authors:  Stanley Sacks; Gerald Melnick; Carrie Coen; Steven Banks; Peter D Friedmann; Christine Grella; Kevin Knight
Journal:  Prison J       Date:  2007-03

2.  Psychiatric disorders among drug dependent subjects: are they primary or secondary?

Authors:  W M Compton; L B Cottler; D L Phelps; A Ben Abdallah; E L Spitznagel
Journal:  Am J Addict       Date:  2000

3.  Psychiatric comorbidity and not completing jail-based substance abuse treatment.

Authors:  Thomas M Brady; Christopher P Krebs; Glen Laird
Journal:  Am J Addict       Date:  2004 Jan-Feb

4.  Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults.

Authors:  Michael L Dennis; Ya-Fen Chan; Rodney R Funk
Journal:  Am J Addict       Date:  2006

5.  Modified therapeutic community treatment for offenders with MICA disorders: substance use outcomes.

Authors:  Christopher J Sullivan; Karen McKendrick; Stanley Sacks; Steven Banks
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

6.  Modified therapeutic community for mentally ill chemical "abusers": background; influences; program description; preliminary findings.

Authors:  S Sacks; J Sacks; G De Leon; A I Bernhardt; G L Staines
Journal:  Subst Use Misuse       Date:  1997-07       Impact factor: 2.164

7.  A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire.

Authors:  M Zimmerman; J I Mattia
Journal:  Arch Gen Psychiatry       Date:  2001-08

8.  Drug abuse treatment process components that improve retention.

Authors:  D D Simpson; G W Joe; G A Rowan-Szal; J M Greener
Journal:  J Subst Abuse Treat       Date:  1997 Nov-Dec

Review 9.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

10.  Screening prison inmates for mental disorder: an examination of the relationship between mental disorder and prison adjustment.

Authors:  F DiCataldo; A Greer; W E Profit
Journal:  Bull Am Acad Psychiatry Law       Date:  1995
View more
  9 in total

1.  A psychometric assessment of the GAIN individual severity scale (GAIN-GISS) and short screeners (GAIN-SS) among adolescents in outpatient treatment programs.

Authors:  Brian D Stucky; Maria Orlando Edelen; Rajeev Ramchand
Journal:  J Subst Abuse Treat       Date:  2013-08-29

2.  A Comparison of Content-Balancing Procedures for Estimating Multiple Clinical Domains in Computerized Adaptive Testing: Relative Precision, Validity, and Detection of Persons With Misfitting Responses.

Authors:  Barth B Riley; Michael L Dennis; Kendon J Conrad
Journal:  Appl Psychol Meas       Date:  2009-12-16

3.  The Relationship Between Drug Use, Drug-related Arrests, and Chronic Pain Among Adults on Probation.

Authors:  Jennifer M Reingle Gonzalez; Scott T Walters; Jennifer Lerch; Faye S Taxman
Journal:  J Subst Abuse Treat       Date:  2014-12-30

4.  Gender differences in comorbid disorders among offenders in prison substance abuse treatment programs.

Authors:  Caron Zlotnick; Jennifer G Clarke; Peter D Friedmann; Mary B Roberts; Stanley Sacks; Gerald Melnick
Journal:  Behav Sci Law       Date:  2008

5.  Performance of the CJDATS Co-Occurring Disorders Screening Instruments (CODSIs) among minority offenders.

Authors:  Alexandra Duncan; Stanley Sacks; Gerald Melnick; Charles M Cleland; Frank S Pearson; Carrie Coen
Journal:  Behav Sci Law       Date:  2008

6.  Diagnostic profiles of offenders in substance abuse treatment programs.

Authors:  Christine E Grella; Lisa Greenwell; Michael Prendergast; Stanley Sacks; Gerald Melnick
Journal:  Behav Sci Law       Date:  2008

7.  Violent offenses associated with co-occurring substance use and mental health problems: evidence from CJDATS.

Authors:  Stanley Sacks; Charles M Cleland; Gerald Melnick; Patrick M Flynn; Kevin Knight; Peter D Friedmann; Michael L Prendergast; Carrie Coen
Journal:  Behav Sci Law       Date:  2009 Jan-Feb

8.  Serious mental illness and negative substance use consequences among adults on probation.

Authors:  Matthew E Rossheim; Melvin D Livingston; Jennifer A Lerch; Faye S Taxman; Scott T Walters
Journal:  Health Justice       Date:  2018-03-22

Review 9.  Mental health screening tools in correctional institutions: a systematic review.

Authors:  Michael S Martin; Ian Colman; Alexander I F Simpson; Kwame McKenzie
Journal:  BMC Psychiatry       Date:  2013-10-29       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.